Pruritus in Patients With Chronic Kidney Disease

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Far Eastern Memorial Hospital
ClinicalTrials.gov Identifier:
NCT01727180
First received: November 12, 2012
Last updated: March 4, 2015
Last verified: March 2015
  Purpose

We believe that knowing characteristics of uremic pruritus is the foundation to investigate its pathophysiology and offer better skin care for patients with chronic kidney disease. We therefore conducted this cross-sectional study to evaluate the characteristics of uraemic pruritus.


Condition Intervention
Kidney Failure, Chronic
Pruritus
Other: Questionnaire based on the McGill Pain Questionnaire

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Cross-Sectional

Resource links provided by NLM:


Further study details as provided by Far Eastern Memorial Hospital:

Primary Outcome Measures:
  • Visual Analog Scale (VAS) [ Time Frame: Once at the entry of the study ] [ Designated as safety issue: No ]
    A visual analog scale (VAS) measuring the general severity of pruritus was reported from 0 to 10 (0 = no pruritus, 10 = worst pruritus imaginable


Enrollment: 108
Study Start Date: June 2011
Study Completion Date: December 2013
Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Chronic kidney disease Other: Questionnaire based on the McGill Pain Questionnaire
Interview questionnaire based on the short form of the McGill Pain Questionnaire

  Eligibility

Ages Eligible for Study:   20 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients with CKD stage 3 to 5D, followed-up in the Far Eastern Memorial Hospital

Criteria

Inclusion Criteria:

  • Adults older than 20 years old, with CKD stage 3 to 5D, with symptoms of pruritus.

Exclusion Criteria:

  • Patients who refused to answer the questionnaire or unable to understand the contents of the questionnaire.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01727180

Locations
Taiwan
Far Eastern Memorial Hospital
New Taipei City, Taiwan, 220
Sponsors and Collaborators
Far Eastern Memorial Hospital
Investigators
Principal Investigator: Hon-Yen Wu, MD Far Eastern Memorial Hospital
  More Information

No publications provided

Responsible Party: Far Eastern Memorial Hospital
ClinicalTrials.gov Identifier: NCT01727180     History of Changes
Other Study ID Numbers: 100047-E
Study First Received: November 12, 2012
Results First Received: March 4, 2015
Last Updated: March 4, 2015
Health Authority: Taiwan: Institutional Review Board

Additional relevant MeSH terms:
Kidney Failure, Chronic
Pruritus
Renal Insufficiency
Kidney Diseases
Renal Insufficiency, Chronic
Signs and Symptoms
Skin Diseases
Skin Manifestations
Urologic Diseases

ClinicalTrials.gov processed this record on April 19, 2015